17-7484820-A-G

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4BS1_SupportingBS2

The NM_000937.5(POLR2A):ā€‹c.56A>Gā€‹(p.Lys19Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000374 in 1,606,282 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 33)
Exomes š‘“: 0.000039 ( 0 hom. )

Consequence

POLR2A
NM_000937.5 missense

Scores

2
2
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.46
Variant links:
Genes affected
POLR2A (HGNC:9187): (RNA polymerase II subunit A) This gene encodes the largest subunit of RNA polymerase II, the polymerase responsible for synthesizing messenger RNA in eukaryotes. The product of this gene contains a carboxy terminal domain composed of heptapeptide repeats that are essential for polymerase activity. These repeats contain serine and threonine residues that are phosphorylated in actively transcribing RNA polymerase. In addition, this subunit, in combination with several other polymerase subunits, forms the DNA binding domain of the polymerase, a groove in which the DNA template is transcribed into RNA. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), POLR2A. . Trascript score misZ 9.1922 (greater than threshold 3.09). GenCC has associacion of gene with neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, autism, susceptibility to, 15.
BP4
Computational evidence support a benign effect (MetaRNN=0.41615275).
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0000392 (57/1454074) while in subpopulation MID AF= 0.000174 (1/5756). AF 95% confidence interval is 0.0000335. There are 0 homozygotes in gnomad4_exome. There are 27 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAdExome4 at 57 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POLR2ANM_000937.5 linkuse as main transcriptc.56A>G p.Lys19Arg missense_variant 1/30 ENST00000643490.2 NP_000928.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POLR2AENST00000674977.2 linkuse as main transcriptc.56A>G p.Lys19Arg missense_variant 1/30 ENSP00000502190 P1
POLR2AENST00000572844.1 linkuse as main transcriptn.201A>G non_coding_transcript_exon_variant 1/101
POLR2AENST00000617998.6 linkuse as main transcriptn.455A>G non_coding_transcript_exon_variant 1/291

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152208
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000306
AC:
7
AN:
228930
Hom.:
0
AF XY:
0.0000241
AC XY:
3
AN XY:
124642
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000565
Gnomad SAS exome
AF:
0.0000348
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000497
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000392
AC:
57
AN:
1454074
Hom.:
0
Cov.:
30
AF XY:
0.0000374
AC XY:
27
AN XY:
722662
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000761
Gnomad4 SAS exome
AF:
0.0000472
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000433
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152208
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000331
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 12, 2021The c.56A>G (p.K19R) alteration is located in exon 1 (coding exon 1) of the POLR2A gene. This alteration results from a A to G substitution at nucleotide position 56, causing the lysine (K) at amino acid position 19 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.31
CADD
Uncertain
24
DANN
Uncertain
1.0
Eigen
Benign
0.18
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Benign
0.52
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.42
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.87
D
Sift4G
Benign
0.24
T
Vest4
0.56
MutPred
0.51
Loss of methylation at K19 (P = 0.0273);
MVP
0.77
ClinPred
0.70
D
GERP RS
5.8
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs751215469; hg19: chr17-7388139; API